Navigation Links
Generex Provides Additional Details for October 21st Live Video Webcast
Date:10/20/2010

be identified by introductory words such as "expects," "plans," "intends," "believes," "will," "estimates," "forecasts," "projects," or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts.  Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not.  Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement.  No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements.  Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.  Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials.  Because of this, statements regarding the expected timing of clinical trials or ultimate regulatory approval cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of clinical trials or when it will obtain ultimate regulatory approval by a particular regulatory agency.  Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.


'/>"/>
SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
2. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
3. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
4. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
5. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
6. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
7. Generex Common Stock to be Quoted on the OTCQB Under the Symbol GNBT Beginning Thursday, October 21, 2010
8. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
9. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
10. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
11. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Albany, New York (PRWEB) July 22, 2014 ... the world. The heat produced by controlled fission chain ... pressure. This steam pressure is used to drive a ... produce approximately 19% of the world’s total electricity production. ... due to several under construction, planned and proposed nuclear ...
(Date:7/22/2014)... Automated cell culture systems are instruments that ... They allow production of optimum cells at a large ... discovery and industries and biopharmaceutical companies. Cell culture automation ... cryobanking, cell-based assays, and cellular expression systems as they ... the Global Cell Culture market will grow ...
(Date:7/22/2014)... 2014 The DNA Spectrum ... visual representation of history, migration, and culture. , ... by family history stories stemming from Europe. His father ... country." Pictures and 8mm home movies painted an elaborate ... family, and Steve ordered a test from DNA Spectrum ...
(Date:7/22/2014)... July 22, 2014 OHAUS Corporation, ... and mechanical balances and scales, proudly announces its ... won Laboratory Equipment magazine’s 2014 “Readers' Choice” Award ... consecutive year the Explorer was voted the best ... Readers’ Choice Awards celebrates “excellence in product design ...
Breaking Biology Technology:Nuclear Energy Market: Global Industry Analysis, Size, Share, Analysis, Growth and Forecast 2013 - 2019 2Nuclear Energy Market: Global Industry Analysis, Size, Share, Analysis, Growth and Forecast 2013 - 2019 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 2DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 3DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 4OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2
... , , , JEFFERSON, N.C., ... give people more confidence to go to work in a pandemic ... products the company developed for the bird flu influenza A subtype ... for the bird flu (H5N1), which never became contagious. The Next ...
... , , SEATTLE, Aug. ... Stephen R. Murray, M.D., Ph.D. as Vice President of ... and protocols at Omeros, and currently is leading the ... include OMS103HP, the Company,s lead candidate being evaluated in ...
... , ... pleased to announce that SK Life Science, Inc. (SKLSI), has licensed Pristima for its Research ... ... a world leader in toxicology and pathology data management solutions and the developer of Pristima™ ...
Cached Biology Technology:Next Safety Releases Advanced Respirator for Infectious Diseases 2Next Safety Releases Advanced Respirator for Infectious Diseases 3Omeros Appoints New Vice President of Clinical Development 2SK Life Sciences has Licensed Pristima 2
(Date:7/22/2014)... DURHAM, N.C. In a cost-effectiveness analysis of commercial ... the drug Qsymia showed the best value for the ... loss, but was also the most expensive option tested, ... Graduate Medical School. , The findings, published in the ... important information on the health and weight-loss benefits per ...
(Date:7/22/2014)... NEW YORK, NY -- As part of a multinational, ... at Mount Sinai have helped identify over 100 locations ... developing schizophrenia, in the largest genomic study published on ... The findings, published online in Nature , point ... and could lead to new approaches to treating the ...
(Date:7/22/2014)... have adapted to New York City,s human behaviour, allowing ... than their fellow squirrels in the woods. , Dr ... & Agriculture, led the study that proved eastern grey ... environments and prevent unnecessary responses when humans acted in ... , "As we rapidly increase the spread of ...
Breaking Biology News(10 mins):Study compares cost-effectiveness of weight-loss programs and drugs 2Study compares cost-effectiveness of weight-loss programs and drugs 3Mount Sinai scientists and international team shed new light on schizophrenia 2Mount Sinai scientists and international team shed new light on schizophrenia 3New York squirrels are nuts about city life 2
... natural coal deposits in the Gulf of Alaska are ... Exxon Valdez tanker catastrophe. This clearly disproves the theory ... environmental damage. PAH pollutants were blamed for the continuing ... Then a dispute erupted over the origins of these ...
... Pasadena, Calif.In a finding that sheds new light on ... the California Institute of Technology (Caltech) have pinpointed the ... The discovery, described in the August 30 ... offer insight into autism and other disorders where social ...
... and some amphibians possess a unique sensory capability in ... to "touch" objects in their surroundings without direct physical ... van Hermmen and his team in the physics department ... basis for this sensory system. What they discover might ...
Cached Biology News:Bioavailable contaminants come from the Exxon Valdez oil catastrophe 2Caltech neuroscientists find brain region responsible for our sense of personal space 2Caltech neuroscientists find brain region responsible for our sense of personal space 3Caltech neuroscientists find brain region responsible for our sense of personal space 4Mathematical keys to a sixth sense -- the lateral-line system 2Mathematical keys to a sixth sense -- the lateral-line system 3Mathematical keys to a sixth sense -- the lateral-line system 4
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: filling ...
Extremely high efficiency packaging extracts useful for transfecting our EpiFOS™ or CopyControl™ Fosmids, or any DNA vector with cos sites. A tremendous value when conpared to the competition...
... A simultaneous dual parameter assay ... poly caspase activity. Active caspases are ... peptide inhibitors, which are cell-permeable, non-cytotoxic ... caspases within the cells. At the ...
... in DMEM and harvested at the log phase ... antigens in their native forms, cells were fixed ... a 12-well (5 mm) adhesive coated slide, with ... attachment and to minimize background staining. Each ...
Biology Products: